Literature DB >> 17109448

Population-based study of renal cell carcinoma in children in Germany, 1980-2005: more frequently localized tumors and underlying disorders compared with adult counterparts.

Barbara Selle1, Rhoikos Furtwängler, Norbert Graf, Peter Kaatsch, Elisabeth Bruder, Ivo Leuschner.   

Abstract

BACKGROUND: Childhood renal cell carcinomas (RCCs) differ histologically and biologically from their adult counterparts. The characteristics of RCC-affected children and their tumors, the influence of treatment, and outcome have so far not been studied in a nonselected, population-based cohort.
METHODS: A retrospective analysis was undertaken of RCC patients less than 16 years old reported to the German Childhood Cancer Registry and to the Kiel Paediatric Tumor Registry from 1980 to 2005.
RESULTS: Forty-nine RCC in children (24 boys, 25 girls) with a median age of 10.6 years were identified. In about every third child possibly RCC-related underlying disorders (tuberous sclerosis, neuroblastoma, teratoma with chemotherapy, Saethre-Chotzen syndrome, chronic renal failure) or related diseases in their family were found. The pathologic subtypes were papillary in 16 (33%), translocation type in 11 (22%), unclassified in 8 (16%), and rarely clear-cell (n = 3) or others. Thirty-four (69%) patients had localized RCC, 8 (16%) patients regional lymph node metastases, and 4 (8%) patients distant metastases. Event-free survival and overall survival rates at 5 years were 96% for localized RCC, 69% and 75% for regional lymph node-positive, 25% and 33% for distant metastatic RCC, respectively. Two of 4 patients with distant metastases received immunotherapy combined with chemotherapy and surgery, both are alive, 1 of them disease-free for 6.9 years.
CONCLUSIONS: Pediatric RCCs are predominantly localized diseases. Children with RCC frequently suffer underlying disorders. Survival rates in localized and regional lymph node-positive cases are favorable. Because of the rarity of RCC in childhood, an international study is necessary. Copyright 2006 American Cancer Society.

Entities:  

Mesh:

Year:  2006        PMID: 17109448     DOI: 10.1002/cncr.22346

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

1.  Pediatric Renal Cell Carcinoma.

Authors:  Elizabeth J Perlman
Journal:  Surg Pathol Clin       Date:  2010-09-01

2.  [Pediatric renal cell carcinoma. A rare differential diagnosis of Wilms' tumor].

Authors:  N Fischer; P J Bastian; J Ellinger; A Simon; U Bode; K Biermann; D Hadizadeh; S C Müller
Journal:  Urologe A       Date:  2008-05       Impact factor: 0.639

3.  Renal cell carcinoma with t(X;17)(p11.2;q25) in a 5-year-old Taiwanese boy: a case report and review of the literature.

Authors:  Chih-Jung Chen; Hui-Ting Hsu; Ming-Tsan Lin; Mariann Pintye; Jim-Ray Chen
Journal:  Pathol Oncol Res       Date:  2011-01-08       Impact factor: 3.201

4.  Characterization of adolescent and pediatric renal cell carcinoma: A report from the Children's Oncology Group study AREN03B2.

Authors:  James I Geller; Peter F Ehrlich; Nicholas G Cost; Geetika Khanna; Elizabeth A Mullen; Eric J Gratias; Arlene Naranjo; Jeffrey S Dome; Elizabeth J Perlman
Journal:  Cancer       Date:  2015-04-06       Impact factor: 6.860

5.  CT and MRI appearances and radiologic staging of pediatric renal cell carcinoma.

Authors:  Ryan T Downey; Jonathan R Dillman; Maria F Ladino-Torres; Jonathan B McHugh; Peter F Ehrlich; Peter J Strouse
Journal:  Pediatr Radiol       Date:  2012-01-17

6.  A rare cause of childhood renal cysts: Xp11.2 translocation renal cell carcinoma.

Authors:  Hakan Taşkınlar; Dinçer Avlan; Çağlar Çıtak; Ayşe Polat; Ali Naycı
Journal:  Can Urol Assoc J       Date:  2015 Jan-Feb       Impact factor: 1.862

Review 7.  Genetics of pediatric renal tumors.

Authors:  Brigitte Royer-Pokora
Journal:  Pediatr Nephrol       Date:  2012-03-30       Impact factor: 3.714

8.  The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing.

Authors:  Mariana M Cajaiba; Lisa M Dyer; James I Geller; Lawrence J Jennings; David George; Dawn Kirschmann; Stephen M Rohan; Nicholas G Cost; Geetika Khanna; Elizabeth A Mullen; Jeffrey S Dome; Conrad V Fernandez; Elizabeth J Perlman
Journal:  Cancer       Date:  2018-06-15       Impact factor: 6.860

9.  A prospective study of pediatric and adolescent renal cell carcinoma: A report from the Children's Oncology Group AREN0321 study.

Authors:  James I Geller; Nicholas G Cost; Yueh-Yun Chi; Brett Tornwall; Mariana Cajaiba; Elizabeth J Perlman; Yeonil Kim; Elizabeth A Mullen; Richard D Glick; Geetika Khanna; Najat C Daw; Peter Ehrlich; Conrad V Fernandez; Jeffrey S Dome
Journal:  Cancer       Date:  2020-09-14       Impact factor: 6.860

10.  Cancer incidence rates and trends among children and adolescents in the United States, 2001-2009.

Authors:  David A Siegel; Jessica King; Eric Tai; Natasha Buchanan; Umed A Ajani; Jun Li
Journal:  Pediatrics       Date:  2014-09-08       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.